Infiphar SRL
Infiphar reported total assets of 565,355 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jul 2026).
The score of Infiphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -74 % Total assets -14 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Infiphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 78,752 € | ||||
| Equity | 97,352 € | ||||
| Cash | 151,746 € | ||||
| EBITDA | 113,222 € | ||||
| Total assets | 565,355 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 12 Jul 2023
- Year ended 31 Dec 2021filed on 08 Jul 2022
Infiphar's financial analysis
- Solvency17.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Infiphar
Infiphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0537.443.148
- VAT number
- BE0537443148
- Peppol
- Registered · 0208:0537443148 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Aug 2013
- Registered office
- 3300 Tienen
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Infiphar (SRL) has been based in Tienen since 2013, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 78,752 € and equity of 97,352 €; its revenue is not published. Its solvency stands at 17.2%, below the median of its sector (44.2%).
Companies similar to Infiphar
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Cawet - Swalue Retail sale of pharmaceutical products Chimay · balance sheet 565,492 €
- Apoteek Termote Retail sale of pharmaceutical products Waasmunster · balance sheet 565,154 €
- Apotheek - Pharmacie Bollen Retail sale of pharmaceutical products Evere · balance sheet 565,052 €
- VAN DE Plas Pharma Retail sale of pharmaceutical products Sint-Genesius-Rode · balance sheet 566,351 €
- Vasseur-Sevrin Retail sale of pharmaceutical products Chastre · balance sheet 567,446 €
- Stragier Retail sale of pharmaceutical products Ath · balance sheet 562,496 €
- Sonapha Retail sale of pharmaceutical products Vaux-sur-Sûre · balance sheet 568,273 €
- Pharm@dvice Retail sale of pharmaceutical products Fexhe-le-Haut-Clocher · balance sheet 571,791 €
Frequently asked questions about Infiphar
What is the revenue of Infiphar?
Infiphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Infiphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0537443148 for Infiphar, if the company is VAT-registered. Its company number (CBE) is 0537.443.148.
Where is the registered office of Infiphar?
According to the CBE register, the registered office of Infiphar is in 3300 Tienen.
What is the equity of Infiphar?
At the close of the 2025 financial year, the equity of Infiphar amounts to 97,352 €, a solvency of 17.2% of total assets.
Who manages Infiphar?
The register lists 1 active mandates at Infiphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Infiphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →